Lobelane analogues as novel ligands for the vesicular monoamine transporter-2

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 12, 2005, Pages 3899-3909

  Zheng, Guangrong ^a   Dwoskin, Linda P ^a   Deaciuc, Agripina G ^a   Zhu, Jun ^a   Jones, Marlon D ^a   Crooks, Peter A ^a  

^a University of Kentucky   (United States)

Author keywords

Lobeline; Methamphetamine; Structure activity relationships; Vesicular monoamine transporter

Indexed keywords

N METHYL 2,6 BIS(2 METHOXYPHENETHYL)PIPERIDINE; N METHYL 2,6 BIS(3 FLUOROPHENYL)PIPERIDINE; N METHYL 2,6 BIS(3 METHOXYPHENETHYL)PIPERIDINE; N METHYL 2,6 BIS(3,4 METHYLENEDIOXYPHENETHYL)PIPERIDINE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; EVALUATION; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN CHEMISTRY; GANGLIONIC STIMULANTS; LIGANDS; LOBELINE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NICOTINIC ANTAGONISTS; RATS; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANCE-RELATED DISORDERS; SYNAPTIC MEMBRANES; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 19444378658     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.04.013     Document Type: Article

References (31)

1. United Nations Office on Drugs and Crimes (UNODC). 2004 World Drug Report. http://www.unodc.org
2. T.E. Nordahl, R. Salo, and M. Leamon J. Neuropsych. Clin. Neurosci. 15 2003 317
3. R.A. Wise Neuron 36 2002 229
4. C. Pifl, H. Drobny, O. Hornykiewicz, and E.A. Singer Mol. Pharmacol. 47 1995 368
5. D. Sulzer, T.K. Chen, Y. Lau, H. Kristensen, S. Rayport, and A. Ewing J. Neurosci. 15 1995 4102
6. T.H. Mantle, K.F. Tipton, and N. Garrett J. Biochem. Pharmacol. 25 1976 2073
7. D.K. Miller, P.A. Crooks, L. Teng, J.M. Witkin, P. Munzar, S.R. Goldberg, J.B. Acri, and L.P. Dwoskin J. Pharmacol. Exp. Ther. 296 2001 1023
8. D.K. Miller, S.B. Harrod, T.A. Green, M.Y. Wong, M.T. Bardo, and L.P. Dwoskin Pharmacol. Biochem. Behav. 74 2002 279
9. S.B. Harrod, L.P. Dwoskin, P.A. Crooks, J.E. Klebaur, and M.T. Bardo J. Pharmacol. Exp. Ther. 298 2001 172
10. S.B. Harrod, L.P. Dwoskin, T.A. Green, B.J. Gehrke, and M.T. Bardo Psychopharmacology 165 2003 397
11. L.P. Dwoskin, and P.A. Crooks Biochem. Pharmacol. 63 2002 89
12. L. Teng, P.A. Crooks, P.K. Sonsalla, and L.P. Dwoskin J. Pharmacol. Exp. Ther. 280 1997 1432
13. R.P. Perera, D.S. Wimalasena, and K. Wimalasena J. Med. Chem. 46 2003 2599
14. D.J. Canney, M. Kung, and H.F. Kung Nucl. Med. Biol. 22 1995 527
15. L.C. Lee, B.T. Vander, P.S. Sherman, K.A. Frey, and M.R. Kilbourn J. Med. Chem. 39 1996 191
16. D.K. Miller, P.A. Crooks, and L.P. Dwoskin Neuropharmacology 39 2000 2654
17. D.K. Miller, P.A. Crooks, G. Zheng, V.P. Grinevich, S. Norrholm, and L.P. Dwoskin J. Pharmacol. Exp. Ther. 310 2004 1035
18. C.A. Briggs, and D.G. McKenna Mol. Pharmacol. 54 1998 1095
19. Zheng, G.; Dwoskin, L. P.; Deaciuc, A. G.; Crooks, P. A. J. Med. Chem., under review
20. P.A. Crooks, M.D. Jones, M.D. Chesnut, A.M. Jaromczyk, and L.P. Dwoskin NIDA Res. Monograph 180 1999 234
21. A.V. Terry Jr., R. Williamson, M. Gattu, J.W. Beach, C.R. McCurdy, and J.R. Sparks Neuropharmacology 37 1998 93
22. D. Flammia, D. Malgorzata, M.I. Damaj, B. Martin, and R.A. Glennon J. Med. Chem. 42 1999 3726
23. G. Zheng, L.P. Dwoskin, and P.A. Crooks J. Org. Chem. 69 2004 8514
24. A.P. Phillips J. Am. Chem. Soc. 72 1950 1850
25. D.R. Howton, and D.R.V. Golding J. Org. Chem. 15 1950 1
26. C.M. Thompson, D.L.C. Green, and R. Kubas J. Org. Chem. 53 1988 5389
27. M. Lautens, and M. Yoshida J. Org. Chem. 68 2003 762
28. J. Lee, and W. Freudenberg J. Org. Chem. 9 1944 537
29. G.R. Newkome, and J.M. Robinson Tetrahedron Lett. 9 1974 691
30. Y.C. Cheng, and W.H. Prusoff Biochem. Pharmacol. 22 1973 3099
31. L. Teng, P.A. Crooks, and L.P. Dwoskin J. Neurochem. 71 1998 258 265